IonQ closed 2025 with a market narrative built on government contracts, photonic interconnect research, and DARPA visibility, the kind of external validation that compresses skepticism and expands price targets simultaneously. The quantum computing sector, riding the tailwind of “World Quantum Day” media cycles and institutional repositioning toward deep-tech themes, rewarded sentiment-driven players generously, with IonQ’s price action serving as the sector’s de facto benchmark for retail enthusiasm. Analyst coverage thickened, upside targets widened, and the implicit assumption embedded in sector-wide price premiums was that commercialization timelines were shortening in a meaningful, monetizable way.
That framing, however coherent it might appear at the sector level, begins to fracture when you look at the actual operating structures underneath it. IonQ’s own revenue base remains modest relative to its valuation, but the company has at least constructed a narrative of hardware-differentiation and government-contract revenue that gives its bull case a structural hook. The operating loss trajectory, while still deeply negative, is paired with a commercialization story that the market can stress-test against contract milestones.
The sector premium, in other words, is being applied to companies that have at least one operational variable pointing in the right direction.
D-Wave Against the Same Metrics IonQ Gets Judged By
D-Wave Quantum enters this comparison in a fundamentally different position. Total revenue for the quarter ended December 31, 2025, per the company’s 10-K filing, came in at $2.8 million, up from $2.3 million in Q4 2024. That year-over-year improvement sounds directionally positive until you place it next to operating expenses of $36.6 million for the same period, because the resulting operating income of -$34.8 million produces an operating margin of -1,266%. A figure that extreme functions less as a ratio and more as a structural description: for every dollar of revenue D-Wave generates from its operations, it spends roughly thirteen dollars more than it takes in. That is a pre-commercial company absorbing the full cost of building a technology that has not yet found its commercial form.
$0.5 million of incremental quarterly revenue against $36.6 million in operating expenses is a rounding error.
What the market appears to be weighting instead is the sector multiple, the quantum narrative, and the assumption that D-Wave’s annealing-based architecture will find a commercial application before the capital runs out. That assumption may not be wrong, but it is doing enormous load-bearing work in a valuation that, as of mid-April 2026, prices the stock at approximately $17.00, down from $28.70 in late January 2026 per market data. A decline of roughly 41% over three months, even as the Nasdaq Composite recovered to 23,639 by April 15 from a March trough near 22,697. QBTS has underperformed the index’s recovery by a wide margin, which is itself a data point the bull case has to absorb.
$20.7 Million in Interest Income and What It Actually Signals
D-Wave’s apparent financial resilience is the variable the market is systematically overweighting. In Q4 2025, per the company’s 10-K, D-Wave recorded $20.7 million in net interest income, a non-operating figure that, when set against the -$34.8 million operating loss, narrows the headline net loss to something that looks more manageable in a screener. Interest income generated from a cash position built through prior equity raises is a sign that the company has not yet spent all of the capital it previously raised. When that cash reserve depletes, or when the interest rate environment shifts, the cushion disappears without any change to the underlying operating structure.
Decomposing the operating margin figure more precisely: the -1,266% margin is a product of $2.8 million in revenue against $36.6 million in operating expenses, of which R&D alone consumed $13.7 million in Q4 2025 per the same filing. If revenue doubles to $5.6 million while operating expenses hold flat, the operating margin moves to approximately -554%. Still catastrophic.
For the margin to reach -100%, where operating losses merely equal revenue, quarterly revenue would need to reach approximately $18.3 million while expenses remain constant, a figure roughly 6.5 times current levels. If expenses grow even modestly alongside revenue, that crossover point moves further out. The directional math suggests that over the next 12 months, D-Wave’s operating losses will remain structurally dominant unless a step-change in commercial contract volume materializes, and no publicly disclosed pipeline supports that scenario.
The counter-scenario deserves honest engagement. If quantum annealing finds a near-term industrial application in optimization problems across logistics, drug discovery, or financial modeling, D-Wave’s first-mover position in annealing architecture could compress that revenue gap faster than a linear extrapolation suggests. The company holds meaningful intellectual property and deployment history. But a technology breakthrough converting to commercial revenue within two to three quarters is a specific claim that requires specific evidence, and that evidence does not appear in the current filing data.
Over the next 12 months, D-Wave’s operating loss will not narrow meaningfully unless quarterly revenue reaches at least $8-10 million, a level more than three times current figures, without a proportional increase in R&D spend, a combination for which no current contract disclosure or revenue guidance provides support. This breaks if D-Wave reports $8 million in quarterly revenue by Q4 2026 while holding operating expenses flat. Until then, the $20.7 million in interest income is carrying a weight the operations cannot.
IonQ’s operating margin, while also deeply negative, is paired with a government-contract revenue structure and hardware differentiation narrative. D-Wave’s margin sits at -1,266% against $2.8 million in revenue, funded by interest on prior raises. Those are not comparable starting points, and the sector multiple treating them as peers is where the mispricing lives. The stock has already retraced 41% from January highs while the operating structure hasn’t moved at all.